1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACTUATE THERAPEUTICS INC.
Actuate Therapeutics Inc. XNAS: ACTU

Actuate Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...

Read More
7.27 0.50 (7.39%)
39.37% Fall from 52W High
105.0K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
0.0 / 100
Momentum Score
Technically Neutral
36.0 / 100
Analyst Price Target
No estimates available

12

S

6

W

2

O

1

T

SWOT Analysis

Actuate Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..